Catalyst Pharmaceuticals
Price & Volume
Stats
See more52W Range | $14.47-$26.15 |
Market Cap | $2.9B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $491.7M |
Revenue Growth (YoY) | 28.3% |
Gross Profit (12 Mos) | $421.1M |
Diluted EPS | $1.31 |
News
See moreYahoo Finance • 2 days ago
What Makes Catalyst Pharmaceuticals (CPRX) an Investment Choice?
Yahoo Finance • last month
Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference
Yahoo Finance • 2 months ago
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025
About
CEO | Mr. Richard John Daly M.B.A. |
CFO | Mr. Michael W. Kalb CPA |
Address | 355 Alhambra Circle, Coral Gables, FL, United States, 33134 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 181 |
